D
Bristol-Myers Squibb Company BMY
$59.01 -$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -8.95B -7.26B -6.54B -6.15B 8.03B
Total Depreciation and Amortization 9.58B 10.18B 10.02B 9.84B 9.77B
Total Amortization of Deferred Charges 0.00 0.00 0.00 28.00M --
Total Other Non-Cash Items 13.75B 11.70B 11.72B 10.36B -2.02B
Change in Net Operating Assets 810.00M 389.00M -1.03B -356.00M -1.91B
Cash from Operations 15.19B 15.00B 14.16B 13.72B 13.86B
Capital Expenditure -1.25B -1.20B -1.22B -1.22B -1.21B
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -21.82B -22.36B -22.33B -21.14B -1.17B
Divestitures 1.10B 1.01B 999.00M 923.00M 909.00M
Other Investing Activities 618.00M 46.00M -141.00M -267.00M -826.00M
Cash from Investing -21.35B -22.50B -22.69B -21.70B -2.30B
Total Debt Issued 15.97B 20.60B 20.49B 20.28B 4.46B
Total Debt Repaid -5.87B -7.99B -5.25B -2.36B -4.00B
Issuance of Common Stock -- 25.00M 27.00M 27.00M 27.00M
Repurchase of Common Stock -- 0.00 -4.00B -4.91B -5.16B
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -4.86B -4.81B -4.78B -4.76B -4.74B
Other Financing Activities -106.00M -87.00M -64.00M -5.00M 0.00
Cash from Financing 5.13B 7.74B 6.43B 8.28B -9.42B
Foreign Exchange rate Adjustments -137.00M 88.00M -27.00M -13.00M 45.00M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -1.17B 325.00M -2.13B 286.00M 2.19B
Weiss Ratings